Track the 랩지노믹스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 랩지노믹스 has published 74 insider filings. Market capitalisation: €43.7bn. The latest transaction was disclosed on 14 July 2026 (Purchase). Among the most active insiders: 이종훈. All data is free.
73
Insider Decl.
n/a
Thresholds
n/a
54 ops.
Buy Volume
n/a
8 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,033 of 28,169 companies
14.3
score / 100
Value
3
Quality
25
FCF yld-49%
Earn yld-98%
EV/EBITDA·
ROE·
Gross mgn35%
Net mgn-73%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
랩지노믹스 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative diagnostic and treatment solutions.